Literature DB >> 12381872

Comparison of the activities of wild type and mutant enhancing factor/mouse secretory phospholipase A2 proteins.

Bhakti M Kirtane1, Rita Mulherkar.   

Abstract

Enhancing factor (EF) protein, an isoform of secretory phospholipase A2 (PLA2), was purified as a modulator of epidermal growth factor from the small intestine of the Balb/c mouse. It was for the first time that a growth modulatory property of sPLA2 was demonstrated. Deletion mutation analysis of EF cDNA carried out in our laboratory showed that enhancing activity and phospholipase activity are two separate activities that reside in the same molecule. In order to study the specific amino acids involved in each of these activities, two site-directed mutants of EF were made and expressed in vitro. Comparison of enhancing activity as well as phospholipase A2 activity of these mutant proteins with that of wild type protein helped in identification of some of the residues important for both the activities

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381872     DOI: 10.1007/BF02705045

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  15 in total

1.  Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages.

Authors:  M Triggiani; F Granata; A Oriente; V De Marino; M Gentile; C Calabrese; C Palumbo; G Marone
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

2.  Enhancing activity and phospholipase A2 activity: two independent activities present in the enhancing factor molecule.

Authors:  S Kadam; R Mulherkar
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Utilization of labeled Escherichia coli as phospholipase substrate.

Authors:  P Elsbach; J Weiss
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Ontogeny of enhancing factor in mouse intestines and skin.

Authors:  S J Desai; R Mulherkar; A S Wagle; M G Deo
Journal:  Histochemistry       Date:  1991

5.  Isolation of a polypeptide that enhances cellular binding of epidermal growth factor.

Authors:  M G Deo; R Mulherkar; S M Mane
Journal:  Indian J Biochem Biophys       Date:  1983-08       Impact factor: 1.918

6.  Further studies on the enhancing factor and its possible mechanism of action.

Authors:  R Mulherkar; M G Deo
Journal:  J Cell Physiol       Date:  1986-04       Impact factor: 6.384

7.  Interfacial catalysis: the mechanism of phospholipase A2.

Authors:  D L Scott; S P White; Z Otwinowski; W Yuan; M H Gelb; P B Sigler
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

8.  Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.

Authors:  A N Fonteh; G Atsumi; T LaPorte; F H Chilton
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  Expression of enhancing factor gene and its localization in mouse tissues.

Authors:  R Mulherkar; S J Desai; R S Rao; A S Wagle; M G Deo
Journal:  Histochemistry       Date:  1991

10.  Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2.

Authors:  B Francis; J M Gutierrez; B Lomonte; I I Kaiser
Journal:  Arch Biochem Biophys       Date:  1991-02-01       Impact factor: 4.013

View more
  1 in total

1.  Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis.

Authors:  Marina Markova; Revati A Koratkar; Karen A Silverman; Vincent E Sollars; Melina MacPhee-Pellini; Rhonda Walters; Juan P Palazzo; Arthur M Buchberg; Linda D Siracusa; Steven A Farber
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.